Top Markets
#1 Islamic Coin Islamic Coin +152.50%
#2 Bitway Bitway +42.48%
#3 Starpower Starpower +38.69%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +33.29%
#5 aelf aelf +28.49%
#6 Pons Pons +26.56%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.55%
#8 SkyAI SkyAI +19.30%
#9 Ocean Protocol Ocean Protocol +16.33%
#10 Bedrock Bedrock +15.75%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Onco-Innovations Ltd. Onco-Innovations Ltd.

Onco-Innovations Ltd.

ONCO
Classifica tra le azioni #29549
Onco-Innovations Ltd. is a Canadian biotechnology company primarily focused on... Onco-Innovations Ltd. is a Canadian biotechnology company primarily focused on pioneering cancer research and developing oncology treatments. A significant offering in their portfolio is ONC010, a product specifically designed for use in cancer therapies. This enterprise was founded on September 16, 2021, and conducts its operations from its headquarters located in Calgary, Canada.
Prezzo delle azioni
$0.47705898
Ultima sincronizzazione: 2026-07-15
Capitalizzazione di mercato
$20.69M
Variazione (1 giorno)
3.17%
Variazione (1 anno)
-65.19%
Paese
CA
Scambia Onco-Innovations Ltd. (ONCO)

Categoria

Healthcare
Rapporto P/B per Onco-Innovations Ltd. (ONCO)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Onco-Innovations Ltd., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Onco-Innovations Ltd. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR